title: Reply.
authors.affiliation: Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.|Florey Institute of Neuroscience and Mental Health, Parkville, Australia.|Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.
authors.forename: Atte
authors.initials: A
authors.lastname: Meretoja
authors.affiliation: University of Manchester, Manchester Academic Health Sciences Centre, Salford Royal National Health Service Foundation Trust, Salford, United Kingdom.|Greater Manchester Neurosciences Centre, Salford Royal National Health Service Foundation Trust, Salford, United Kingdom.
authors.forename: Adrian
authors.initials: A
authors.lastname: Parry-Jones
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D010949:Plasma; D012042:Registries; D014812:Vitamin K / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D014812:Vitamin K